News & Updates

Show Multimedia Only

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025 by

Broad-class psychotropic exposure during pregnancy is not associated with an increased risk of obstetric or neonatal complications, although certain subclasses may carry higher risks, according to a 19-year population-based study in Hong Kong.

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

26 Sep 2025

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025 by

Hormone therapy for vasomotor symptoms (VMS) appears to raise the risk of atherosclerotic cardiovascular disease (ASCVD) for women exposed to the treatment later in life, according to a secondary analysis of two Women’s Health Initiative (WHI) trials.

Menopausal hormone therapy poses cardiac risk for older women

24 Sep 2025

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

23 Sep 2025

Exposure to computed tomography (CT) imaging prior to pregnancy appears to increase the risks for spontaneous pregnancy loss and congenital anomalies, suggests a study. However, the mechanism driving this association remains unclear.

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

23 Sep 2025

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

22 Sep 2025 by

Hypertensive disorders of pregnancy (HDPs) appear to increase the odds of adverse neurodevelopmental and cognitive outcomes, such as autism and attention-deficit/hyperactivity disorder (ADHD), in the offspring, suggest the results of a meta-analysis.

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

22 Sep 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

22 Sep 2025

New drug applications approved by US FDA as of 1-15 August 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

22 Sep 2025

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025 by

Among women who have previously had an ischaemic stroke, the use of vaginal estradiol tablets does not raise the risk of having another stroke, according to new research.

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

18 Sep 2025

Myo-inositol supplementation of no help in pregnant women with PCOS

16 Sep 2025

Daily myo-inositol supplementation does not appear to reduce the risk of pregnancy complications such as gestational diabetes, preterm birth, and pre-eclampsia in women with polycystic ovary syndrome (PCOS), according to a study.

Myo-inositol supplementation of no help in pregnant women with PCOS

16 Sep 2025

PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer

15 Sep 2025 by

Adjuvant chemoradiotherapy (CRT) improves both 10-year overall survival (OS) and recurrence-free survival (RFS) in women with high-risk endometrial cancer vs pelvic radiotherapy alone, with the most clinically relevant benefit observed in p53 abnormal cancers, according to the 10-year analysis of the phase III PORTEC-3 trial.

PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer

15 Sep 2025

Postpartum bleeding lower with prophylactic carbetocin vs oxytocin

13 Sep 2025 by

First-line prophylactic treatment with carbetocin during the third stage of labour works better than oxytocin at reducing the risk of postpartum haemorrhage (PPH), according to a study from Australia.

Postpartum bleeding lower with prophylactic carbetocin vs oxytocin

13 Sep 2025

Does maternal cancer affect offspring development?

13 Sep 2025 by

Children exposed to maternal cancer and its treatment show no significant disruptions in their cardiac, neurocognitive, or physical development during adolescence, reveals a study.

Does maternal cancer affect offspring development?

13 Sep 2025

News & Updates

Filter by Specialty:

Specialty:

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

19-year HK data: No causal link between maternal psychotropic exposure and obstetric complications

Menopausal hormone therapy poses cardiac risk for older women

Menopausal hormone therapy poses cardiac risk for older women

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

Exposure to CT scan may raise risks for pregnancy loss, congenital anomalies

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

Hypertensive disorders of pregnancy may impair childhood neurodevelopment

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-August-2025

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

Vaginal estrogen tablets unlikely to increase risk of stroke recurrence

Myo-inositol supplementation of no help in pregnant women with PCOS

Myo-inositol supplementation of no help in pregnant women with PCOS

PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer

PORTEC-3: Adjuvant chemoradiotherapy improves 10-year OS in high-risk endometrial cancer

Postpartum bleeding lower with prophylactic carbetocin vs oxytocin

Postpartum bleeding lower with prophylactic carbetocin vs oxytocin

Does maternal cancer affect offspring development?

Does maternal cancer affect offspring development?